Egypt signs deal with US' Dawah Pharmaceuticals to qualify Gypto Pharma for FDA standards
3 Articles
3 Articles
Egypt’s Gypto Pharma, US Dawa Pharmaceuticals sign strategic alliance
Egypt's Gypto Pharma (Medicine City) and US-based Dawa Pharmaceuticals signed a strategic alliance agreement on Tuesday aimed at strengthening Egypt's pharmaceutical industry and achieving US Food and Drug Administration (FDA) qualification for Gypto Pharma's facilities. Egyptian Prime Minister Mostafa Madbouly witnessed the signing ceremony at the government headquarters in the New Administrative
US & Egypt Expand Commercial Ties with Landmark Partnership Between Dawah Pharmaceuticals & Gypto Pharma
US Ambassador to Egypt Herro Mustafa Garg joined His Excellency Prime Minister Dr. Mostafa Madbouly, Minister of Investment and Foreign Trade Engineer Hassan Al-Khatib, and Minister of Planning, Economic Development, and International Cooperation Dr. Rania Al-Mashat, at a signing ceremony between American company Dawah Pharmaceuticals and Egyptian company Gypto Pharma. The agreement between Dawah Pharmaceuticals, a leader in critical therapies, …
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage